Elizabeth Porfido is currently on a leave of absence from the firm on a secondment.
Elizabeth Porfido assists clients in complex civil antitrust litigation, government review of mergers and acquisitions, filing obligations under the Hart-Scott-Rodino Act, and counseling clients in relation to antitrust issues.
Elizabeth graduated from Brooklyn Law School magna cum laude in 2021. During law school, Elizabeth served as a legal intern at the Housing Conservation Coordinators, an IP & Data Privacy legal intern for a luxury goods company, and as a judicial intern for the Honorable Kiyo Matsumoto in the Eastern District of New York. Elizabeth also served as an executive articles editor of the Brooklyn Journal of Corporate, Financial & Commercial Law.
- Pfizer in its US$6.7 billion acquisition of Arena Pharmaceuticals.
- Bristol-Myers Squibb in its US$4.1 billion acquisition of Turning Point Therapeutics.
- J.D., Brooklyn Law School, 2021, magna cum laude
- B.A., Skidmore College, 2014
- New York